# Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers

> **NCT01481597** · PHASE1 · COMPLETED · sponsor: **Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** deuteporfin
- **DRUG:** deuteporfin
- **DRUG:** deuteporfin
- **DRUG:** deuteporfin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01481597
- **Lead sponsor:** Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481597, "Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01481597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*